Chugai launches PiaSky in Taiwan for treatment of paroxysmal nocturnal hemoglobinuria
Chugai Pharmaceutical Co., Ltd. announced that Chugai Pharma Taiwan Ltd. (CPT), a wholly-owned subsidiary of Chugai, has launched PiaSky, a drug created by Chugai, on October 1 for “the treatment of the patients 13 years and older with paroxysmal nocturnal …